MediWound
MDWD
76 hedge funds and large institutions have $104M invested in MediWound in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 10 closing their positions.
93% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 15
80% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 10
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
21% more capital invested
Capital invested by funds: $86M → $104M (+$18.1M)
12.37% more ownership
Funds ownership: 41.1% → 53.47% (+12%)
12% more funds holding
Funds holding: 68 → 76 (+8)
64% less call options, than puts
Call options by funds: $732K | Put options by funds: $2.06M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$6.31M |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$4.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.42M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.42M |
| 5 |
Millennium Management
New York
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$2.84M |
| 2 |
LCM
Legato Capital Management
San Francisco,
California
|
-$836K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$621K |
| 4 |
BlackRock
New York
|
-$491K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$370K |
MDWD Hedge Fund Activity: Q3 2025 in Review
76 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q3 2025, worth a combined $104M — up 21% from $86M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new MDWD positions and 10 closed out — a net gain of 8 holders — while 29 added to existing stakes and 15 trimmed.
The largest buyer was Rosalind Advisors, adding an estimated $6.31M. The largest seller was Essex Investment Management, exiting entirely with an estimated $2.84M sold.
- 76 institutional investors held MediWound (MDWD) as of Q3 2025, up from 68 in Q2 2025.
- Funds reported $104M of MediWound stock for Q3 2025, up 21% quarter-over-quarter.
- 18 funds opened new MediWound positions in Q3 2025 and 10 closed out, a net change of +8 holders.
- The largest MediWound buyer in Q3 2025 was Rosalind Advisors, an estimated $6.31M added.
- The largest MediWound seller in Q3 2025 was Essex Investment Management, an estimated $2.84M sold.
Based on aggregated 13F filings for Q3 2025.